Roche Media Mar 4, 2026 Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche Media Mar 4, 2026 Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche Media Mar 4, 2026 Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche Media Mar 4, 2026 Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche Media Feb 24, 2026 Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
Roche Media Feb 23, 2026 Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma
Roche Media Feb 20, 2026 Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Roche Media Feb 19, 2026 Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Endpoints News Feb 9, 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Roche Media Feb 9, 2026 Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche Media Feb 9, 2026 Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech